| 发明名称 | Heterocyclic compound | ||
| 摘要 | A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.;Specifically, a compound represented by the following formula (I):; wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. | ||
| 申请公布号 | US9428470(B2) | 申请公布日期 | 2016.08.30 |
| 申请号 | US201514619464 | 申请日期 | 2015.02.11 |
| 申请人 | Takeda Pharmaceutical Company Limited | 发明人 | Ikeda Zenichi;Sasaki Minoru;Kakegawa Keiko;Kikuchi Fumiaki;Nishikawa Yoichi |
| 分类号 | C07D261/04;C07D413/10 | 主分类号 | C07D261/04 |
| 代理机构 | Foley & Lardner LLP | 代理人 | Foley & Lardner LLP |
| 主权项 | 1. A compound which is (5R)-3-(3-((4-Carbamimidamidobenzoyl)oxy)phenyl)-5-(carboxymethyl)-4, 5-dihydro-1,2-oxazole-5-carboxylic acid or a salt thereof. | ||
| 地址 | Osaka JP | ||